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RESEARCH ARTICLE Open Access
Does total hip replacement affect sexual
quality of life?
Rita Th. E. Harmsen1, Tsjitske M. Haanstra1*, Inger N. Sierevelt2, Elise P. Jansma3, Peter A. Nolte4,
Melianthe P. J. Nicolai5, Peter D. H. Wall6 and Barend J. Van Royen1
Abstract
Background: Total Hip Replacement (THR) is an effective treatment for end-stage hip osteoarthritis. Since the
introduction of total joint replacement, the effect on the Sexual Quality of Life (SQoL) following THR has been
addressed in scant studies. The aim of our study was to systematically review the literature, to summarise effects
of THR on patients’ SQoL.
Methods: We searched PubMed, EMBASE and PsycINFO between January 1970 and February 9th, 2015 with
search terms including Total Hip, Osteoarthritis, SQoL, and THR. Eligible studies were identified and two independent
authors extracted data including details of SQoL, study quality and risk of bias.
Results: There were 12 eligible studies, which included a total of 2099 patients with an age range of 20–85
years. The methodological quality of ten studies was rated as low, and of two as moderate. Amongst the majority of
patients, SQoL improved after surgery, both in terms of physical-functional and psychosocial well-being. However,
changes between pre-operative and postoperative SQoL ranged extensively: for example, Sexual Dysfunction Δ 8–51 %
and Sexual Activity (SA) Δ 0–77 %. Three studies reported that some patients never resumed SA again after surgery.
Conclusion: In over 40 years of THR treatment, scant studies have examined the effect of THR on patients’ SQoL. This
review suggests that SQol improves after THR, although the magnitude of effects varies highly. However, the quality of
the supporting evidence was rated as low to moderate. This suggests a need for more high quality evidence about the
effects of THR on SQoL.
Keywords: Sexual Quality of Life, Total Hip Replacement, Hip (osteo)Arthritis
Background
Hip Osteoarthritis (HA) causes pain and affects func-
tion, social interactions and Sexual Function (SF) in
patients [1, 2]. It has been established that these func-
tions can generally be restored by Total Hip Replace-
ment (THR) [3, 4]. The improvement in surgical
techniques and the durability of the implants today have
led to a growing number of patients undergoing joint re-
placement. Consequently, this patient population is
growing and becoming both older and younger [5–7].
The effect of THR can—in part—be measured in terms
of health-related quality of life [3, 4]. Quality of Life (QoL)
is a subjective and multidimensional indicator: it comprises
a range of domains including functional ability and phys-
ical, emotional and social well-being [8]; it also includes
Sexual Quality of Life (SQoL) [9]. The World Health
Organization (2006) defines Sexual Health as “a state of
physical, emotional, mental and social well-being in relation
to sexuality” [10]; hence, it can be said that SQoL is an im-
portant part of general well-being, and improvements in
SQoL have indeed been associated with improvements in
general health related quality of life [10, 11].
As human beings can be sexually active at all ages [12],
the total number of sexually active patients undergoing THR
will increase. Given the fact that SF is seldom discussed,
[12], Sexual Difficulty (SD) might be under-diagnosed in
patients with HA; however, while there are some recent
international studies into this topic [13–15], an overview of
the literature is lacking. The aim of this study, therefore, was* Correspondence: t.haanstra@vumc.nl1Department of Orthopaedic Surgery, VU University Medical Center
Amsterdam, De Boelelaan 1117, Amsterdam 1081 BT, The Netherlands
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to provide a systematic review of the literature, with the
aim of summarising the effects of THR on patients’ SQoL.
Methods
This systematic review was undertaken in accordance
with the PRISMA (Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses) system [16].
Data sources and searches
We searched electronically in PubMed, EMBASE and
PsycINFO (by EBSCO). We also performed a hand
search of reference lists of included articles to identify
additional relevant studies. The search strategy was de-
veloped in collaboration with a medical database special-
ist (EPJ). The PubMed search strategy, which can be
found in Appendix 1, was adapted for the other data-
bases. The search included articles from January 1970
until February 9th, 2015. The searches included MeSH
terms in PubMed, EMtree in EMBASE, thesaurus terms
in PsycINFO as well as free text terms. Search terms
expressing “total hip” and “osteoarthritis” were used in
combination with “sexual quality of life” and “THR”
treatment. Search results were imported to a reference
manager (Mendeley), and duplicates were removed.
Study selection
Titles and abstracts were screened using the following
eligibility criteria:
 Studies describing SQoL in patients with primary
and or secondary HA undergoing THR were
included if they measured SQoL after or before and
after THR; studies that only assessed SQoL before
surgery were excluded.
 Homogeneous cohorts of Ankylosing Spondylitis (AS)
or Rheumatoid Arthritis (RA) in combination with
SQoL were excluded because of the systemic illness
and multiple joint involvements interfering with SQoL.
 Studies describing SQoL in patients undergoing
THR and Total Knee Replacement (TKR) were
excluded if data could not be split up.
 Studies solely assessing expectations about SQoL
before and or after surgery were excluded.
 Studies not written in English, German or Dutch
were excluded, because of capacity reasons.
 Reviews, editorials, case studies and legal cases were
excluded.
 Studies with no full text available through the Dutch
Interlibrary Loan System (IBL) were also excluded.
Two reviewers (RH and EPJ) independently applied the
eligibility criteria to the titles and abstracts. Where there
was uncertainty about eligibility, the full text was exam-
ined. Titles and abstracts that were identified as potentially
eligible were selected for full-article review. The two re-
viewers independently screened the full-text articles for
final study inclusion. Disagreements would have been
resolved by a third author (TH), but this did not occur.
There are no other data found in supplementary files.
Al data that support our findings are contained within
this manuscript.
Data extraction
Two reviewers (RH and IS) extracted data from the in-
cluded studies, independently and into pre-determined
forms, and included the patients’ demographics, such as
disease characteristics, study aims and information about
study designs (e.g. sample size, response rate, ages, gen-
der, duration of follow-up, and analysis methods). SQoL
outcomes were subsequently extracted and categorised
into two dimensions of SQoL: physical-functional well-
being and psychosocial well-being. We summarised the
data into outcomes quantifying SQoL before and after
surgery, as a result of surgery (changes in SQoL) and as
postoperative (cross-sectional) outcomes.
Assessment of methodological quality
Two reviewers (RH and IS) independently scored the meth-
odological quality of the included studies. Quality was
assessed by using 17 of the 23-items quality checklist previ-
ously employed by Schouffoer [17] and Tilbury [18]. This
checklist is based on Hayden [19] and Shamlyan [20] and is
divided into 3 categories: selection bias (items 1–6), infor-
mation bias (items 7–14), and statistical analysis bias (items
15–17). This quality checklist can be found in Appendix 2.
Items concerning multiple determinants were not included.
Risk of bias was considered to be present if one or more
of the items within one category were scored as “unclear”,
“negative” or “not described”. When the study represented
“high” quality on all items per category, the quality was
rated as “0” (absence of risk of bias). When risk of bias
was present, or items were not completely or not clearly
described, it was rated as “1”. The quality of the study was
rated as “high” if there was no risk of selection bias, infor-
mation bias, or statistical analysis bias. The quality was
rated as “moderate” if there was evidence of risk of bias in
one of the three categories, and as “low” if there was risk
of bias in two or all categories.
Data syntheses
We planned to statistically pool data from studies that were
clinically and methodologically homogeneous. However, be-
cause of the methodological heterogeneity of the studies,
further statistical pooling of data was not possible.
Results
We identified 250 references (88 in PubMed, 159 in
EMBASE, 3 in PsycINFO, and 3 additional records by
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reference checking) and removed 67 duplicates, after
which 12 papers met the eligibility criteria for final ana-
lysis. The PRISMA flowchart is presented in Fig. 1.
Study characteristics
Studies were published between 1973 and 2015. Four
studies were undertaken in North America and Canada,
three of which in the USA [15, 21, 22] and one in Canada
[4]. Six were undertaken in Europe: two in the UK [23,
24], one in Denmark [25], one in Sweden [3], one in
France [26], and one in the Netherlands [27]; two were
undertaken in Asia: one in South Korea [13] and one in
China/Japan [14].
Seven of the studies were longitudinally designed [3, 4,
14, 21, 24, 25, 27], and five retrospectively [15, 22, 23,
26, 28], comprising a total of 2099 patients undergoing
THR, 60 % of which were males and 40 % females. Seven
of the included studies described SQoL before and or
after THR multi-dimensionally, and as the main question
[13–15, 22–24, 26]; the other five described SQoL more
indirectly, as one of the outcomes of a broader research
question [3, 4, 21, 25, 27]. For example, two studies fo-
cused on Quality of Life (QoL) after THR [3, 4], one on
function and pain after THR [21]; one translated and vali-
dated the Oxford Hip Score questionnaire into Dutch
[27], and one focused on alternative outcome measures
after THR in young patients [25]. The number of
participants in the studies ranged from 22 [21] to 791 [15]
and their ages from 20 [22] to 86 [21]. Seventeen RA pa-
tients (divided into 5 studies) and five AS patients (indi-
cated in 1 study) are present in this review, as they were
part of a group of respondents of which the results were
not presented separately. The duration of follow-up
ranged between the first post-operative routine visit [22]
to a mean of 2.3 (+0,8) years after THR [15]. The charac-
teristics of the included studies that assessed SQoL in pa-
tients after THR are presented in Table 1.
Methodological quality
The methodological quality was rated as “moderate” in two
studies [14, 15] and “low” in ten studies [3, 4, 13, 21–27]. A
full description of the methodological quality of all the
studies is shown in Table 2, and the individual scores on all
items of the methodological quality assessment can be
found in Appendix 3. Unclear study participation, sampling
and study attrition caused a risk of selection bias in five
studies [13, 21–23, 26]: for example, poor response rates or
loss of follow up (more than 30 % was considered
inappropriate), unrepresentative cohort study populations
(e.g. including only satisfied patients) and unclear pre-
sented study details about reasons for loss to follow-up.
Inadequate use of validated outcome tools for the
measurement of outcomes (inclusive method and
Records screened
(n= 186)
Records excluded  
(n=159)
15 Full-text articles  
excluded :
- Editorial (n=1)
- RA: (n=1)
-THR data not split up: (n=1)
- Reviews (n=4)
- Diverse surgical proc.(n=2)
- Only pre-operative (n=5) 
- Double published (n=1)    
(thesis)
Articles included in qualitative 
synthesis
(n = 12)
Records identified through database searching (n = 250)
Additional record identified through reference checking (n = 3) 
Total (n=253)
After duplicates removed (n 67) 
Total (n=186) 
Full-text articles assessed for 
eligibility
(n =27)
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Fig. 1 Flowchart of the search and selection procedure of the studies
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Table 1 Characteristics of the included studies assessing the effects of THA on SQoL
First author, country Study design Aim/Objective N of patients
(Response Rate)
Diagnosis n (%) Main inclusion criteria Mean Age
(years)
n (%), Male n (%), Female Duration of
follow up,
after surgery
Todd 1972 UK Retrospective,
cohort studyd
Interview (Int)
and Survey
Incidence of SD and
influence of THR on
SQoL
Int: 123/292
(42 %) Surv:
79/134 (58 %)
HAa Patients undergone THR
with active sexual
relationship at time of
onset HA;
Interview NA
M61 (30–79)
F 60 (29–79)
Interview
NA 49(40)
36 (46)
Interview
NA 74(60)
43 (54)
Int: NA Surv:
NA
Wiklund 1991 Sweden Case-control
study, Survey
To evaluation of QoL
before and after THR
in patients with HA
56/57 (98 %)g Prim. HA: 40 (71 %)
Sec. HA: 16 (29 %)
incl 1 RAb
Patients with HA < 80
year; awaiting THR
65 (30–79) 21 (38) 35 (63) 1 year
Stern 1991 USA Retrospective,
cohort study,
Survey
To determine the
effect of THR on SF
incl. sexual positions
and resumption SA
after THA
86/100 (86 %) Prim. HA: 74 (86 %)
Sec. HA: 12 (14 %)
of which 4 dysplasia
and 8 RAb
Patients with predominantly
HA all undergone THR and
<70 y, all satisfied about
results THR
57 (20–70) 39 (45) 47 (55) At time
postoperative
routine visit
Laupacis 1993 Canada Prospective,
double-blind
randomized
trial, Survey
Effect of THR on
health related QoL
188/ 251 (75 %) HAa Patients with HA, < 75
years, no severe OA of
other hip, no previous
THR or THK (knee) < 5 years,
nor infectious arthritis
64 (40–75) 97 (53) 91 (47) 3 months 6
monthsh
1 year 2 year
Gogia 1994 USA Prospective
cohort study,
Survey
Developing evaluation
system to assess
clinical outcome of
THR related to
changes in functional
status and pain
22/24 (92 %) HAa Patients with HA,
undergoing THR; alert
oriented, ambulatory
with or without assistive
devices
69,2 (57–86) 4 (18) 18 (82) 3 and 6
monthsh
Gosens 2005, The
Netherlands
Prospective,
multicentre
cohort study,
Survey
Translating and
validating Oxford Hip
Score into Dutch
146/150 (100 %) Prim. HA: 117 (78 %)
Sec. HA: 33 (22 %)
Age >35 year; patients
awaiting THR; No systematic
illness and physically and
mentally suitable,
understanding Dutch
language
65 (38–85) 52 (35) 98 (65) 7 weeks, 3
months, 6
monthsh;
1 year; 2 year
First author, country Study design Aim/Objective N of patients
(Response Rate)
Diagnosis n (%) Main inclusion criteria Mean Age
(years)
n (%), Male n (%), Feale Duration of
follow up,
after surgery
Laffosse 2007 France Retrospective,
cohort study,
Survey
SD in patients before
and after THR;
receiving sufficient
information
135/346 (39 %) Prim. HA: 56 (42 %) <65 year, undergone THR
min. 6 months previously;
Revision and Femoral
Neck Fracture excluded
51,8 (22–65) 77 (57) 58 (43) ≥6 months
Sec. HA: 76 (58 %)
Incl. 3 RAb
Wall 2011 UK Prospective
cohort study,
Survey
To determine the
effect of HA on SQoL
and to assess wheter
a SQoL is considered
in surgical plan
86/100 (86 %) Prim. HA: 74 (86 %) <75 Year, undergoing THR,
living with a partner
62 (48–74) 39 (45) 47 (55) 6 months
Sec. HA: 12 (14 %)
Incl. 3 RAb
Yoon 2013 Korea Retrospective,
cohort study,
To determine concerns
related to SQoL; to
64/512 (13 %) Sexual active patients
during previous last
50e 45 (NA) 19 (NA) ≥6 months,
at routine
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Table 1 Characteristics of the included studies assessing the effects of THA on SQoL (Continued)
face-to-face
interview
determine changes in
SA after THR
Prim. HA: 11 (17 %)
Sec. HA: 53 (83 %)
Incl. 2 RAb, 5 ASd
year, No dislocation,
infection or stiffness.
follow up
visit
Wang 2014 Japan Prospective,
multicentre
cohort study,
Survey
To evaluate the influence
of ONFH and THR on
SQoL
247/300 (82 %) Sec. HA: all males,
ONFH patients (247)
SA married adults,
only ONFH males,
Age >25- < 60.
Excluded severe
comorbiditiesf
46,8 (34.7–58.9) 247 (100) 1 year
Nunley 2014 USA Retrospective
multicentre
cohort study,
Survey
To evaluate SQoL in
young active patients
following THR.
791/806 (98 %)c Prim. and non
inflammentoire Sec.
HAa
≤60 year; THR and
SRA patients, no
history postoperative
complications UCLA
score >6i
49,5 (42.3–56.7) 531 (66) j 275 (34) j 2,3 years
(±0,8)
Klit 2014 Denmark Prospective
multicentre
cohort study,
Survey
To explore any -positive
or negative- effect
THR have had on
sexual function, sexual
frequency and sexual
practice, in younger
THR patients
136/153 (89 %) Young HAa patients
awaiting THR: n86)
(Hip Resurfacing:
n44)
<60 Year, undergoing
primary THR/HR, not
suffering from
cognitive dysfunction
or malignant disease,
able to fill in
questionnaire
53 (48–57) 68 (50) 68 (50) 3 months
6 months
1 year h
aUnspecified numbers and HA type
bSome RA and AS patients were included because data could not slit up
cUsed modern bearing surfaces: SRA = Surface Replacement Arthroplasty; SRA treatment: n 122 (15 %) (181 control patients)
d started with interview, continued with survey
eMean age derived
fComorbidities e.g. affecting heart lung, liver, kidneys; patients under medications; psychiatric history; having mental retardation
gControl group not specified
hduration of follow up used in this review
iPre-symptomatic activity score of University of California Los Angeles (UCLA)
jN not corrected by gender (-15 respondents)
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setting), and inadequate or incomplete reporting of con-
founding variables, caused a risk of information bias in
eleven studies [3, 4, 13, 15, 21–27].
Three studies were only descriptive [23, 24, 27].
Statistical bias was observed in eleven studies due to
unclearly described missing values and a lack of proper
statistical analysis (e.g. multivariate analysis methods was
considered appropriate) [3, 4, 13, 14, 21–27]. Only one
study performed multivariate analysis [15].
Outcomes
Studies used a number of terms to describe SQoL, and
these terms were categorised into two main-groups, and
several subgroups of SQoL:
A. Physical-functional well-being, categorised into three
sub-groups:
 Sexual Dysfunction (SD),
 Sexual Function (SF), and terms categorised as
 Sexual Activity (SA), for example, “coital
frequency”, “resuming time of SA”, and “hip
interfering with SA”.
B. Psychosocial well-being of SQoL, categorised into six
sub-groups as:
 “Need for information” (or “not able to obtain
information”),
 “SD was an argument to undergo THR”,
 “Effects on relationship”,
 “Effects on sexual satisfaction”,
 “Effects on sex quality”, and
 “Concerns” (e.g. “concerns from partner”, “fear of
dislocation”, “decreased sexual desire”, “arousal
difficulty”, “loss of libido”, and “felt hip slipping
out” during SA).
Subsequently, we summarised the differences between
pre- and postoperative outcomes in Table 3 as “Changes
in SQoL after THR”, and the cross-sectional measured
postoperative outcomes of SQoL were summarised in
Table 4.
Changes in SQoL
Differences between pre- and postoperative outcomes,
defined as changes in SQoL after THR (Table 3), were
reported in 10 studies [3, 4, 14, 21–27].
Six studies reported a physical-functional change in SD
after surgery [3, 22, 23, 25–27] which ranged from Δ 25–
51 % [3, 22], and by gender between Δ 8–20 % for males
and Δ 16–29 % for females [25, 26]. Males preoperatively
had less SD than women, women showed greater improve-
ment after THR in three studies [23, 25, 26]. Positive
changes between pre-operative and postoperative SA were
reported in five studies [4, 14, 21, 24, 25], and ranged
widely from Δ 0 to 77 % [14, 24]. Two studies reported a
change in hip-pain during SA, respectively Δ 53 % and Δ
56 % [14, 21], while hip-mobility increased in one study
(Δ 54 %) [14]. Two studies reported positive changes in
SA: one reported an increase of “coital frequency” (Δ 73 %)
[22], and one an improvement in “SA” (Δ 44 %) [4]. Two
studies reported that the preoperatively sexual active
patients had regained SA after THA [24, 25]; both
reported a postoperative loss of follow-up (Table 3).
Two studies reported changes in psychosocial out-
comes of SQoL [14, 24]. One of those, reported an in-
crease in the patients’ “need for information” after THR
of Δ 28 % [24]; the other study (only males) reported re-
duced “impairment of relationship” (Δ -37 %) (p = 0.026)
and a change on “sexual satisfaction of patients” of Δ 40 %
(p = 0.018) [14]. One study assessed associations between
Table 2 Methodological Quality Rating of the 12 included studies
Study Selection bias
presenta
Information bias
presenta
Statistical analysis
bias presenta
Total bias Score Level of Qualityb
Todd et al. 1973 [23] 1 1 1 3/3 L
Wiklund and Romanus 1991 [3] 0 1 1 2/3 L
Stern et al. 1991 [22] 1 1 1 3/3 L
Laupacis et al. 1993 [4] 0 1 1 2/3 L
Gogia et al. 1994 [21] 1 1 1 3/3 L
Gosens et al. 2005 [27] 0 1 1 2/3 L
Laffosse et al. 2008 [26] 1 1 1 3/3 L
Wall et al. 2011 [24] 0 1 1 2/3 L
Yoon et al. 2013 [13] 1 1 1 3/3 L
Wang et al. 2014 [14] 0 0 1 1/3 M
Nunley et al. 2015 [15] 0 1 0 1/3 M
Klit et al. 2015 [25] 0 1 1 3/3 L
a1 = bias present or unclear; 0 = no bias present
bH = high quality: no evidence for selection bias, information bias or statistical analysis bias (not available); M =Moderate Quality: one or two aspects rated as bias
present or unclear; L = Low quality: all three aspects rated as bias present or unclear. THR = Total Hip Replacement
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Table 3 Changes of SQoL after THR
Study Quality
level
Physical-Functional
Outcomes of SQoL
Psychosocial
Outcomes
of SQoL
n in
study
Pre-operative n Post-
operative n
Pre operative %
(n) (score)
Post-operative %
(n) (score)
Δ SQoL
in %
Directionc
of Change
p value
Todd, et al. 1973 [23] L SD in Females:
None
Slight
Considerable
Intercourse Ended
123 74 74
39(29)
12(9)
16(12)
32(24)
59(44)
15(11)
5(4)
20(15)
20
3
-11
-12
+
+/-
+
+
SD in Males:
None
Slight
Considerable
Intercourse ended
49 49
61(30)
16(8)
8(4)
14(7)
76(37)
12(6)
0(0)
12(6)
15
- 4
- 8
- 2
+
+
+
+/-
Wiklund and
Romanus 1991 [3]
L SD 57 57 56 34 9 -25 + 0.001
Stern, et al. 1991 [22] L SD
None
Slight
Severe
Extreme
86a 86 83
14(12)
40(34)
38(33)
8(7)
65(54)
34(28)
1(1)
0(0)
51
- 6
-37
- 8
++
+
+
+
<0.001
SF: Coital Frequency
per month
3,3 5,7 73d +++ <0.001
Laupacis, et al. 1993 [4] L SF: decreased SA
(score 0–10; with 0
points being the
best score)
188 33b 27b 74(7,4) 30(3,0) −44 ++
Gogia, et al. 1994 [21] L Pain during SA
(score 1–5; with 5
points being the
best score)
22 7 7 47(2.36) 100(5) 53 ++
Gosens, et al. 2005 [27] L SD due to hip:
Never
Sometimes
Often
Most of time
Always
150 146 144
43(63)
16(23)
6(9)
12(17)
23(33)
78(112)
15(21)
1(1)
4(6)
3(4)
35
- 1
- 5
- 8
-20
+
+/-
+/-
+
+
Laffosse, et al. 2008 [26] L SD:
None:
Minimal:
Moderate:
Severe:
Extreme:
135 135 89
30(40)
21(29)
30(40)
16(22)
3(4)
53(47)
21(19)
26(23)
0(0)
0(0)
23
0
- 4
-16
- 3
+
+/-
+/-
+
+/-
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Table 3 Changes of SQoL after THR (Continued)
SD: Females
None:
Minimal:
Moderate:
Severe:
Extreme:
58 57 42
14(8)
19(11)
37(21)
25(14)
5(3)
43(18)
19(8)
36(15)
0(0)
2(1)
29
0
-1
-25
- 3
+
+/-
+/-
+
+/-
0.004
SD: Males
None:
Minimal:
Moderate:
Severe:
Extreme:
77 77 48
40(31)
23(18)
25(19)
10(8)
1(1)
60(29)
23(11)
17(8)
0(0)
0(0)
20
0
- 8
-10
- 1
+
+/-
+
+
+/-
0.13
Wall, et al. 2011 [24] L Hip Interfering with
SA:
86 71 54 77(55) 0(0) −77 +++
Like more information
provided:
55(39) 83(45) 28 +
Wang, et.al 2014 [14] M Effect on:
SF (scale 0–8; with
0 points being the
best score)
247 247 247 29(2.3) 23(1.8) −6 + 0.14
Hip-pain during SA
(scale 0–10; with 0
points being the
best score)
65(6.5) 9(0.9) −56 ++ 0.009
Hip-mobility during
SA (scale 1–5; with
5 points being the
best score)
28(1.4) 82(4.1) 54 ++ 0.012
Effect on:
Impairment relationship
(scale 0–8; with 0 points
being the best score)
66(5.3) 29(2.3) −37 ++ 0.026
Overall sexual satisfaction
patients (scale 1–5; with
5 points being the best
score)
54(2.7) 94(4.7) 40 ++ 0.018
Overall sexual satisfaction
partner (scale 1–5; with
5 points being the best
score)
76(3.8) 86(4.3) 10 + 0.4
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Table 3 Changes of SQoL after THR (Continued)
Klit, et al. 2015 [25] L SD due to hip Females
(f OHS scale 0–6; with
6 points being the
best score)
136 68 68 67(4.0) 83(5.0) 16 + 0.008
SD due to hip Males
(fOHS scale: 0–6; with
6 points being the
best score)
68 68 92(5.0) 100(6.0) 8 + 0.102
SF: SA before and
at twelve month
follow upe
136 108 83 100(108) 100(83) 0 +/-
SD Sexual Difficulty or Sexual Dysfunction, SF Sexual Function, SA Sexually Active patients
aOnly satisfied patients (with results THR)
bPatients were asked to choose five most adversely affected activities (n33)
cRating the direction of change:
Positive effect: + (5–35 %); ++ (35–70 %); +++ (>70 %)
Negative effect: - (−5 to−35 %); – (−35 to−70 %); — (>−70 %)
Unchanged: +/- (between 0 and 5 %; between 0 and - 5 %)
dIncrease 2.4 times: 2.4/3.3 (.73)
eOnly SA patients were included
fOHS = Oxford Hip Score: scale 0–6 (score 0 means “due to other reason than hip”; this was not included in statistics)
Thus, 1 = no sex life able due to hip; 6 never disabled by the hip)
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Table 4 Postoperative outcomes of SQoL
Study Quality
level
Physical-Functional Outcomes
of SQoL (n in study)
Psychosocial outcomes
of SQoL (n in study)
Postoperative n (%) p value
Todd, et al. 1973 [23] L Relief SD: Females (n 32/37)a:
Complete
Considerable
Slight
Nil
4 (13 %)
12 (38 %)
6 (19 %)
10 (31 %)
-
Relief SD: Males (n 22/23)b
Complete
Considerable
Slight
Nil
6 (27 %)
5 (23 %)
2 (9 %)
9 (41 %)
-
(n 60) Need for more advice 34 (57 %)
Stern, et al. 1991 [22] L SF: Time to resume (n75/86):
1–2 months
≤1 month
≥2 months
Females = males
41(55 %)
8 (11 %)
26 (34 %)
males sooner
<0.01
(n 64) Need for more advice 57 (89 %)
Argument to undergo THR: 15 (20 %)
Laffosse, et al. 2008
[26]
L SF: Coital Frequency (n130/135)
Increased:
Unchanged:
Decreased:
24 (18,5 %)
91 (70 %)
15 (11,5 %)
Increased, more women than men 0.02
Not able to obtain information 110 (83 %)
Argument to undergo THR: 21 (18,5 %)
SF: Resuming time (n 135)
Females (n 58)
Males (n 77)
Never having resumed again
(n77)
66,5 days (4–365)
87 days (4–365)
54 days (5–210)
3 (2 %)
0.0005
Wall, et al. 2011 [24] L Overall effect on SA (n 53/86):
Much better
Better
No Change
Worse
Much worse
44 (81 %)
9 (17 %)
0
0
0
Concerns partner:
(Fear hurting spouse)
7/54 (12 %)
Yoon, et al. 2013 [13] L Time to resume SA: (n 64/64) 6,19 months
(3weeks - 48months)
Difficulty with leg positioning
(females more than males)
25 (39 %) 0.045 #
Changing Sexual Positions
(more frequently for patients with
diff. leg positioning)
26 (40,6 %) <0.01
- Muscle weakness (Males n 6) 11 (17,2 %)
Not able to obtain information 51/62 (80 %)
Concerns
- Fear of dislocations
Males
Females
33 (51,6 %)
23/45 (51 %)
10/19 (53 %)
Effect on relationship (males):
Lack of understanding spouse 3 (4,7 %)
Effect on satisfaction:
- Same
- Increase
- Less
44 (68,8 %)
15 (23,4 %)
5 (7,9 %)
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pre- and postoperative SQoL and clinical and demo-
graphic characteristics, and found no correlation (p > 0.05)
between these variables and postoperative SQoL [14].
Postoperative outcomes of SQoL
Seven studies reported cross-sectional outcomes [13, 15,
22–26] (Table 4); mostly because they were designed
retrospectively [13, 15, 22, 23, 26]. Physical-functional
outcomes of SQoL were extracted from these seven stud-
ies [13, 15, 22–26]. SD was reported in one study [23]:
51 % females and 50 % males had complete to consider-
able relief of SD after THR. Six studies reported on SF
[13, 15, 22, 24–26] including two that reported on
increased “coital frequency” [15, 26] in 18.5 and 43.5 %
of the patients, respectively; coital frequency stayed un-
changed in 70 and 52 %, respectively, and it decreased in
11.5 and 4.5 %, respectively. Four studies reported on the
“time to resume SA” [13, 22, 25, 26]: the majority of the
patients (>50 %) resumed SA within 2 months [22, 26];
one Eastern study reported a mean of 6.9 months (3 weeks
- 48 months) [13]. Females (87 days) resumed later than
males (54 days) (p = 0.0005) [26]. “Decreased SA” was
mostly affected by pain, mobility and apprehension [15].
In one study, three patients never resumed SA again [26],
and one study reported that 3 males (4 %) under 60 years
experienced erectile dysfunction after THA [25].
Table 4 Postoperative outcomes of SQoL (Continued)
Satisfaction correlated to stress ≤stress =
≥satisfaction
0.03
Nunley, et al. 2015
[15]
M SA since surgery (n 791)c
No Sexual Activity (due to operative
hip)
708 (89,5 %)
10 (1,3 %)
# 0.0061
Odds 1.953
Sex Frequency:
- Less:
- Same:
- More:
n 694
31 (4,5 %)
361 (52 %)
302 (43,5 %)
# ‘less’
<0.0001
Odds 0.130
# ‘More’
<0.001
Odds 3.422
If ‘more’ caused by:
- less pain
- greater mobility
- less apprehension
294 (98 %)
288 (95,4 %)
224 (74,5 %)
Sex quality compared to 1 month
prior surgery
- Worse:
- Same:
- Better:
(n 697)
'
13 (2,2 %)
195 (28 %)
487 (69,9 %)
# ‘Better’
<0.0001
Odds 10.596
If ‘better’ caused by:
- less pain
- greater mobility
481 (98,8 %)
458 (94,2 %)
-less apprehension 310 (64,2 %)
Concerns at least one episode
Felt hip slipping-out during
SA (instability)
22 (3,1 %)
Had to limit SA due to operation 81 (11,6 %) # <0.0016
Odds 3.150
Klit, et al. 2015 [25] L Time to resume SA (n 136)
≤ 8 weeks
> 8 weeks
55/83 (66 %)
10/83 (12 %)
Sexual Frequency: females 12 % increase 38 %
better abilities
sexual praxis
84 % of them experienced
associated increased ROM,
decreased pain and fear
Sexual Frequency: males No changes
Erectile dysfunction: males 3/68 (4 %)
SD Sexual Dysfunction, SF Sexual Function, SA Sexual Activity
a adjusted for 5 = ‘No reply’
b adjusted for 1 = ‘No reply’
c within the past year #Comparison of SA, Quality and Frequency between THR and Control cohort with Odds ratios
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Psychosocial outcomes of well-being were reported in six
studies [13, 15, 22–24, 26]. Two studies reported on the
need for more advice, ranging from 57 to 89 % [22, 23]; two
reported that 80 % of the patients were not able to obtain
information [13, 26]; and two studies mentioned SD as an
argument to undergo THR [22, 26]. Two studies reported
on the terminology subgroups “effect on relationship”, “ef-
fect on satisfaction”, “sex quality” and “concerns” [13, 15].
One study examined “effect on relationship” as the lack of
understanding from the spouse (in 4.7 %, only males) [13];
in this study, satisfaction increased in 23.4 %; stayed the
same in 68.8 % and decreased in 7.9 % [13]. One study
found “sex quality” was experienced as better after surgery
in 69.9 %, and experienced as worse in 2.2 % [15].”Con-
cerns” were quantified in three studies [13, 15, 24]: in one
study, 51.6 % of patients worried about fear of dislocation
[13]; in another, the spouses worried about hurting the part-
ner [24]; a third study reported that 3.1 % of the patients
felt their hip was slipping out during SA after surgery [15].
Discussion
In this systematic literature review we summarised the
effects of THR on SQoL as reported in 12 studies pub-
lished between January 1970 and early 2015. We found
that overall the majority of studies included in this review
saw an improvement in SQoL after surgery for the major-
ity of patients, in terms of both physical-functional and
psychosocial well-being. However, the magnitude of this
effect varied highly, which may be due to methodological
and cultural differences between studies.
The difference between pre-operative and postopera-
tive SD ranged from Δ 8–51 % [22, 25], and the differ-
ence between pre-operative and postoperative SA ranged
even more extensively: Δ 0–77 % [14, 24]. This review
further suggests that there are differences between men
and women and between European/North American and
Asian patients in terms of resuming SA. In addition, four
studies reported that the majority of patients (50–80 %)
did not receive sufficient information about what to
expect of SQoL after THR [13, 22–24]. One study re-
ported that the patients’ need for information changed
after the operation (Δ 28 %): the patients would have
liked more information after surgery. Another subject of
possible misinformation is the time to resume SA again
and the fear of hip dislocation after THR [13].
Surprisingly, some studies described SF as an adverse
event of THR: one study reported 4 % erectile dysfunction
in males after THR [25], and two (retrospective) studies re-
ported some patients who never resumed SA again after
surgery [15, 26]. This finding was somewhat unexpected;
however, we found one additional study that supported this
finding [29]. This additional study reported that 26.1 % of
the males lost the erectile function they had preoperatively,
while 6.7 % never regained normal erections again after
surgery [29]. We did not find evidence for a true associ-
ation or a causal link between erectile dysfunction and the
surgery itself, and the author suggests his findings could be
the result of major surgery at a higher age [29].
We found some gender differences in postoperative
SA—men resumed sooner than women. We also found
geographic differences [22, 26]: the majority of Western
(Europe and North America) patients resumed SA within
2 months, in accordance with recommendations of
Western orthopaedic surgeons [24, 30]; the majority of
Eastern (Asia) patients resumed after 6.9 months [13]. We
found neither recommendations nor additional literature
of Asian orthopaedic surgeons. It is possible that discuss-
ing sexuality with physicians is a sensitive topic in Asian
cultures [13, 31]. However, it has been reported that West-
ern patients do not raise the subject spontaneously either
[32]: even surgeons rarely address the issue [30]. There-
fore, problems with SQoL in patients undergoing THR
could be under-diagnosed in the East and the West alike.
Some studies reported additional comments of patients:
two studies reported that in nearly 20 % of patients SD was
an argument to undergo THR [22, 26]. Four studies men-
tioned that patients stated they would have welcomed a
booklet with additional information [2, 22, 23, 26]. In
addition, Currey (1970) suggests that patients want to be
adequately informed and prefer to obtain the information
from the person with the most knowledge of the pathology
[1]. However, it has been described that addressing SQoL is
difficult and uncommon for both doctors and patients
[33, 34]. We suggest that this lack of communication
causes unnecessary concerns: for example, it appears
that patients are fearful of hip dislocation after surgery [13].
Dahm, Jacofsky and Lewallen found that 20 % of the
members of the American Association of Hip and Knee
Surgeons reported knowledge of patients experiencing
dislocation during SA [30]. However, we found no litera-
ture indicating SA as a direct cause of dislocation, nor
evidence-based guidelines about safely resuming SA after
THR. We did find a recent (2014) motion-capture study
that analyses the kinematics of the hip joint during the
twelve”most common sexual positions” [35]. This study
provides guidance on safe sexual positions, by gender, and
describes that sexual positions for women require more
hip mobility, and therefore have a higher risk for disloca-
tion. This is confirmed by Lavernia et al. [36]. We suggest
that it is a task of orthopaedic surgeons to provide good
guidelines, as patients might otherwise try to seek infor-
mation from the so-called “grey” literature that is available
on the Internet. This “grey” information is potentially both
inadequate and inaccurate [37].
Comparisons with other studies
Our systematic review is, to our knowledge, the first that
summarises SQoL after THR. However, we are aware of
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one recent narrative review that reports the same beneficial
but heterogenic effects of THR on SQoL [38], and we
found a literature review of RA and sexuality, published in
1999, which reviewed 19 eligible papers with predomin-
antly the same results [39]. Nonetheless, studies into SQoL
and surgical hip treatment in the orthopaedic literature are
few and far between: The first study was published in 1970,
which corresponds to the time that the THR technique
was being developed and gradually became safer [1].
However, since then, scant studies have acknowledged
SQoL, and of the twelve studies included in this review,
five were published more than 20 years ago. Although the
methodology of the newer studies (after 2005) is more
advanced, and recent studies show more depth of analyses
of the topic, the overall results of the studies do not differ
essentially between older and more recent studies.
Methodological implications
We rated ten of the twelve included studies methodologic-
ally as “low” because they had numerous sources of risk of
bias; and eleven studies lacked multivariate analyses
methods. Five of the twelve studies were retrospectively de-
signed, however, in our opinion, these studies were useful
for focussing on the study question of SQoL more thor-
oughly, identifying detailed information and “feasibility is-
sues for future longitudinal research” about SQoL after
THR [40]. Generally speaking, we suppose investigating
SQoL is complex because it is a sensitive issue. However,
Fenton et al. (2001) suggest that sexual behaviour research
is as difficult as other areas of self-reported behaviour, in-
cluding diet, smoking, and alcohol consumption” [41], and
they conclude that “continued methodological research is
needed to better identify the sources of measurement
error.” [41].
Additionally, the included studies paid little attention to
comorbidities and other potential confounders. For ex-
ample, a review concerning SQoL in psoriasis patients
found that diabetes, hypertension or depression could play
an important causal role towards erectile dysfunction [42],
and another review suggests that the use of beta-blockers
and diuretics may also have negative effects on SF [43].
Given the average age of THR patients, these confounders
will likely be present in a considerable part of the hip popu-
lation. The available studies further paid little attention to
gender-specific complaints and outcomes; in addition,
whereas females generally outnumber males in THR treat-
ment [7], our review includes 60 % males, which indicates
selection bias, and this is only partly explained by the fact
that one great cohort-study included only men [14].
Strengths and weakness
Our review was characterized by a number of different −
prospectively and retrospectively measured − heteroge-
neously defined factors of SQoL. This caused marked
heterogeneity; consequently that data synthesis was not
possible. Moreover, we may have missed potentially
eligible studies in other languages as well as studies on
QoL that mention SQoL in the full text only. Although we
intended to exclude studies about SQoL in RA and or AS
patients (because of the systemic illness and the multiple
joint involvements interfering with SQoL), we decided to
include 5 studies in which the majority of the patients had
OA, but a minority were RA or AS patients (between 2
and 11 % of the population). In these studies data were
not presented separately for the different diagnosis and
therefore the total samples were included in this review.
This may have slightly biased the results of our review.
Directions for further research
SQoL in patients with HA, before and after THR, is gain-
ing importance as the total number of patients increases
and the age range of patients broadens. Given the rising
number of patients worldwide, we feel that SQoL should
be better quantified routinely, for example by using Patient
Reported Outcome Measures (PROMs) that are validated
for this particular purpose. Longitudinal representative co-
hort studies would be helpful to accurately understand SD,
beginning at the early stages, through to end-stage HA and
postoperatively after THR.
Conclusion
This systematic review covers scant research of over
more than 40 years. The limited number of studies show
an overall improvement of SQoL after THR, however
with a very large range in the magnitude of the effect.
The quality of evidence in the included studies was low
to moderate. Our results do indicate that patients have a
need for more information, and with the total amount
and growing yearly numbers of THR procedures world-
wide, it is now clear that more research is warranted to
provide information about the effects of THR on SQoL.
It is only with this accurate information that we can ef-
fectively inform patients about what to expect for their
SQoL after THR.
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Appendix 1
Table 5 Search strategy in PubMed February 9, 2015 (read from bottom-up)
Set Search terms Result
#5 #5 NOT (“addresses”[Publication Type] OR “biography”[Publication Type] OR “comment”[Publication Type] OR “directory”
[Publication Type] OR “editorial”[Publication Type] OR “festschrift”[Publication Type] OR “interview”[Publication Type] OR
“lectures”[Publication Type] OR “legal cases”[Publication Type] OR “legislation”[Publication Type] OR “letter”[Publication
Type] OR “news”[Publication Type] OR “newspaper article”[Publication Type] OR “patient education handout”[Publication
Type] OR “popular works”[Publication Type] OR “congresses”[Publication Type] OR “consensus development conference”
[Publication Type] OR “consensus development conference, nih”[Publication Type] OR “practice guideline”[Publication
Type]) NOT (animals[mh] NOT humans[mh])
88
#5 #3 AND #4 97
#4 “Sexuality”[Mesh] OR “Sexual Behavior”[Mesh] OR “Sexual Dysfunction, Physiological”[Mesh] OR “Sexual Partners”[Mesh]
OR sexual*[tiab] OR “sex behavior”[tiab] OR “sex behaviour”[tiab] OR SQOL[tiab]
221959
#3 #1 OR #2 60706
#2 “Arthroplasty, Replacement, Hip”[Mesh] OR “Hip Prosthesis”[Mesh] OR ((“Arthroplasty”[Mesh:NoExp] OR “Arthroplasty,
Replacement”[Mesh:NoExp] OR “Arthrodesis”[Mesh] OR Arthroplasties[tiab] OR Arthroplasty[tiab] OR Arthrodes*[tiab]
OR Prosthes*[tiab] OR Implant*[tiab] OR replacement*[tiab] OR revision[tiab] OR Arthrodes*[tiab]) AND (“Hip”[Mesh]
OR “Hip Joint”[Mesh] OR Hip[tiab] OR hips[tiab]))
43562
#1 “Osteoarthritis, Hip”[Mesh] OR “Hip Contracture”[Mesh] OR Coxarthrosis[tiab] OR Coxarthroses[tiab] OR “Femur Head
Necrosis”[Mesh] OR Femur Head Necros*[tiab] OR Femur Head osteonecros*[tiab] OR ((“Joint Diseases”[Mesh:NoExp]
OR “Arthritis”[Mesh:NoExp] OR “Osteoarthritis”[Mesh:NoExp] OR Osteoarthr*[tiab] OR Arthriti*[tiab] OR arthro*[tiab])
AND (“Hip”[Mesh] OR “Hip Joint”TMeshl OR hipftiab] OR hipsftiab]))
41398
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Appendix 2
Table 6 Checklist used for the assessment of the methodological quality of the included studies
Theoretical background Used for selection bias
1. Is there a theoretical background for the hypothesis?
Study participation
2. Is the study population clearly described in terms of age, gender, and important patients’ characteristics? Used for selection bias
3. Is the percentage of eligible subjects who participated in the study (response rate) adequate?
(More than 30 % is considered inappropriate)
Used for selection bias
Sampling
4. Are patients who participated in the study similar to eligible non-participants (the population),
in terms of age, gender, and important disease characteristics?
Used for selection bias
Study attrition
5. Is the percentage of subjects available for analysis adequate? (<30 % not too many missing values
or loss to follow-up)?
Used for selection bias
6. Were reasons for loss to follow-up presented and assessed during the study for possible systematic
attrition? (Subjects that did not finish the study)
Used for selection bias
Outcome measurement
Definition of outcome variable(s) Used for information bias
7. Are clear definitions of each outcome variable provided?
8. Is clear operationalization of each outcome variable provided? How is it measured? Used for information bias
Measurement of outcome variable(s) Used for information bias
9. Are the measurement instruments used for the measurement of the outcome variable(s) reliable and valid?
Method and setting of the outcome variable(s) Used for information bias
10. Were the measurement approach, time and place of measurement of the outcome variable(s)
standardized or conducted in a way that limits systematically different measurement?
Study confounding
Definition of potential confounders Used for information bias
11. Are clear definitions of each confounder provided?
12. Is clear operationalization of each confounder provided? Used for information bias
Measurement of potential confounders Used for information bias
13.Are the measurement instruments used for the measurement of the confounder(s) reliable and valid?
Method and setting of the confounder(s) Used for information bias
14. Were the measurement approach, time and place of measurement of the confounder(s)
standardized or conducted in a way that limits systematically different measurement?
Statistical analyses
15. Is the percentage of missing values adequate? Less < 30 % Used for statistical analysis bias
16. Were multivariable analyses performed? Yes is rated as “0” if yes Used for statistical analysis bias
17. Was it clearly described which variables were included in the (multivariable) model(s)? Used for statistical analysis bias
Based on Hayden and Shamliyan, and used by Tibury [18, 20]
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